RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 10/16/26
Followers: 439
Posts Today: 0
Views Today: 17974

CYDY Stock Quote & Tools

$0.2283 ▲ +0.0229 (+11.14%) As of Oct 16, 3:59 PM EDT
Last0.2283
$ Chg0.0229
Open0.2050
High0.2300
Beta1.4964
Year High0.397
Market Cap335.42M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.68M
Volume3.96M
% Chg+11.14%
Prev Close0.2054
Low0.2050
VWAP0.21542
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. nmbr1stckpckr

    Thanks!

  2. ohm20

    Dr. Patterson is wrong. COVID-19 deaths are not due to the cytokine storm.

    (1)
  3. MD VIROLOGIST

    "claimed"? The results of the the open label trial were impressive. The prospective double

    (3)
  4. CDiddy

    I agree. If they were concerned about the trial, they would have recommended a change to the PE

    (6)
  5. gestalt2

    I was thinking about this when the discussion about dosing amount. If the DSMC was asking for a 42

    (3)
  6. KenChowder

    Hmm, I guess I never paid attention. Do we even have secondary endpoints? Primary

    (1)
  7. onestepahead

    For strictly EUA purposes I dont think there is any reason why 42 day If it was that much better

  8. reallypeople?

    42 days . Would of liked that change . Who thinks that number of days in the trial would of been

  9. nmbr1stckpckr

    Hmm, I guess I never paid attention. Do we even have secondary endpoints?

  10. reallypeople?

    Wish one of our secondary endpoints was ventilater free survival at 28 days .. Easy to keep SOC

  11. reallypeople?

    They bought a company that has IP for the inhaled form of avviptidal

  12. ohm20

    Tell us what you think of the claimed actions of RLF-100 in relation to

    (1)
  13. PatientLong

    Agree. A person selling is just a small cog in the massive thing we call the market. The market has

    (4)
  14. sean007

    On another board, it was suggested 30 Million short..... THAT is a lot to cover.

  15. sean007

    That reply and alleged statements from Nader..do NOT sound like happy camper time.....and if

    (2)
  16. bigO

    Agree. A person should not be vilified for selling.

  17. CDiddy

    Low volume. Some people are hedging. Meaning if they take some profits now, they lock in a win

    (1)
  18. mountaineer

    I just shared as well......Keep on Keepn' on!!

  19. dfwl28

    "And we are only seeing a few million traded everyday." Read More:

    (1)
  20. MarcS

    Someone doing a good job of spreading the word:

    (10)
  21. MarcS

    Good question. Who said anything about CYDY? Umm, thought we were on a CYDY stock

    (3)
  22. onestepahead

    Not for cd-12 trial which primary endpoint is mortality dont need to measure RO for 28 day

    (2)
  23. bigO

    Interesting that Bruce said the all CCR5 trials need a RO test. Does our CD12 trial have RO tests?

  24. Bobbythebus

    K ty

  25. Shelly2626

    And we are only seeing a few million traded everyday. The majority of everyone invested here

    (2)
  26. Shelly2626

    If people believe no early news is bad news ...they are really thinking wrong as this takes the

    (3)
  27. Enjay

    Another article about Coronavirus variants The following article was posted today on IPIX's

    (1)
  28. onestepahead

    No one literally no one is selling. Price is down because of the shorts and the MM manipulation.

    (4)
  29. Bobbythebus

    I agree with that

  30. reallypeople?

    I speculate that its people thinking the delay means bad news . That delay is on their timeline

    (1)
  31. Enjay

    Vyrologix Long Hauler Study Dr. Norman Gaylis, a rheumatologist in FL, is looking for long

    (3)
  32. HCIT

    Who knows calstang. It could be like I've been saying all along that some entity is giving money

    (2)
  33. Shelly2626

    No one that I know ..... ..but then again some people look at the same sunrise differently

    (1)
  34. Bobbythebus

    Who would be selling at this juncture? Hmm

  35. Shelly2626

    I think we bear good results by beginning next week ...maybe Tuesday since that's my bday

  36. AlwaysSum1ElsesFault

    End of Immunity: South African NICD says new variant has mutated to the point that a significant

    (3)
  37. Enjay

    New tweet from Dr. Patterson re CytoDyn (his reply is at bottom) @TPenn39777458 Replying to

    (4)
  38. calstang

    HCIT Wrote: Dipping? Sure is & CDEL is doing just that, slamming us again dropping the bid

    (1)
  39. sean007

    Perhaps he doesn't have a vested interest/axe to grind with HGEN....could you explain this matter

    (1)
  40. KenChowder

    Sorry, Lang. I had completely forgotten that you were the person who'd made the disparaging remark

    (2)
  41. Bw

    Ya they killed the momentum .. And it had some they just soaked all the shares up ( hidden seller )

    (1)
  42. nmbr1stckpckr

    I think the volume of CYDY shares traded today is running lower than yesterday. So I doubt HGEN

    (1)
  43. JLang

    Literally went to Feuerstein's twitter to see the fury unleased on those dirty endpoint-shoppers at

    (2)
  44. nmbr1stckpckr

    You forgot 'at least until more LL is produced'.

    (2)
  45. HCIT

    Dipping? Sure is & CDEL is doing just that, slamming us again dropping the bid calstang. This has

    (1)
  46. CDiddy

    I hope HGEN does get approved. They will be used in moderate patients, and we will be used in

    (2)
  47. calstang

    HGEN has not completed their trial. RLFTF did complete their trial end of December, the 30th I

    (1)
  48. reallypeople?

    Hardest to save if your not getting LL . Get it . .

    (2)
  49. CDiddy

    We allow people on ventilation. We are trying to save lives, and EIND data showed that we could.

    (7)
  50. calstang

    HGEN IMO is dipping because the news was generally perceived as negative, and weak knees investors

    (2)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Siili Solutions Unveils Exciting Employee Share Savings Plan

Updated Category News Views 120

Siili Solutions Introduces New Employee Share Savings Plan Siili Solutions Plc has recently taken a significant step to enhance employee engagement by approving a new plan period for its employee share savings plan, known as SiiliX Share. This announcement highlights the company’s commitment to fostering a culture of shared ownership and providing employees with an...

Continue Reading
Celldex Shares Exciting Insights at Major Investor Events

Updated Category News Views 118

Celldex's Participation in Key Investor Conferences Management from Celldex (NASDAQ:CLDX) recently announced their upcoming participation in several investor conferences aimed at providing insights into the company's innovative work in immunology. These events are pivotal platforms for investors and stakeholders to engage with industry leaders and gain insights into the...

Continue Reading
TSMC's Recent Export License Boosts Market Confidence and Operations

Updated Category News Views 110

TSMC Experiences Positive Market Sentiment Taiwan Semiconductor Manufacturing Company Limited (NASDAQ: TSM) shares saw an encouraging rise of 2.74% in premarket trading, reaching $312.25. This positive movement followed the recent granting of an annual export license by the U.S. Department of Commerce, which allows TSMC to import advanced chipmaking equipment to its...

Continue Reading
Fennec Pharmaceuticals Highlights Participation at Key Healthcare Conference

Updated Category News Views 1167

Fennec Pharmaceuticals Participating in Healthcare Conference In a significant announcement, Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a leader in specialty pharmaceutical innovations, has confirmed its participation in an engaging and insightful fireside chat as part of the Piper Sandler 37th Annual Healthcare Conference. This event is set to take place on...

Continue Reading
Transforming Housing in Canada with GroundBreak Ventures

Updated Category News Views 179

Introducing Future Housing Canada GroundBreak Ventures has launched an innovative national platform, Future Housing Canada, dedicated to modernizing housing delivery in Canada. This comprehensive web portal provides a clear guide for government officials, builders, developers, and industry stakeholders looking to tackle the pressing housing challenges faced across the...

Continue Reading